Discover Opportunities months before the RFP drops
Learn more →Handheld chemical analyzer capable of rapid analytical measurement and non-destructive analysis spectrometry
Posted Date
Oct 28, 2025
Due Date
Nov 21, 2025
Release: Oct 28, 2025
Close: Nov 21, 2025
Handheld chemical analyzer capable of rapid analytical measurement and non-destructive analysis spectrometry
Innovation in biologics manufacturing: Biologics (e.g., antibody) compatible cell free production capability that can support pre-clinical testing and potentially produce 5-10k dose lots of GMP drug substance. Innovations in biologics manufacturing process control (e.g., digital twins). Technologies to reduce biologics drug substance/product release time and/or enable real-time release.
Posted Date
Oct 28, 2025
Due Date
Dec 22, 2025
Release: Oct 28, 2025
Close: Dec 22, 2025
Innovation in biologics manufacturing: Biologics (e.g., antibody) compatible cell free production capability that can support pre-clinical testing and potentially produce 5-10k dose lots of GMP drug substance. Innovations in biologics manufacturing process control (e.g., digital twins). Technologies to reduce biologics drug substance/product release time and/or enable real-time release.
AvailableFor end-to-end untargeted genomic sequencing workflows appropriate for military use. To survey current industry capabilities in the engineering, testing, and manufacturing of solutions capable of the following: Genomic Sequencing Workflows: End-to-end, untargeted genomic sequencing workflows appropriate for military users with varying levels of technical expertise. Automation of process steps is highly desirable. Workflows must accommodate both environmental and clinical sample matrices. Field-Deployable Bioinformatics Tools: Bioinformatics tools optimized for field use, capable of detecting indicators of genetic engineering and identifying potential biological threats regardless of taxonomic classification. Test & Evaluation (T&E) Infrastructure: Technologies and infrastructure necessary for government-led T&E of untargeted sequencing approaches. Protein Toxin Sequencing: Capabilities for protein toxin sequencing, including both mobile laboratory-based systems and field-deployable platforms.
Posted Date
Oct 28, 2025
Due Date
Dec 19, 2025
Release: Oct 28, 2025
Close: Dec 19, 2025
For end-to-end untargeted genomic sequencing workflows appropriate for military use. To survey current industry capabilities in the engineering, testing, and manufacturing of solutions capable of the following: Genomic Sequencing Workflows: End-to-end, untargeted genomic sequencing workflows appropriate for military users with varying levels of technical expertise. Automation of process steps is highly desirable. Workflows must accommodate both environmental and clinical sample matrices. Field-Deployable Bioinformatics Tools: Bioinformatics tools optimized for field use, capable of detecting indicators of genetic engineering and identifying potential biological threats regardless of taxonomic classification. Test & Evaluation (T&E) Infrastructure: Technologies and infrastructure necessary for government-led T&E of untargeted sequencing approaches. Protein Toxin Sequencing: Capabilities for protein toxin sequencing, including both mobile laboratory-based systems and field-deployable platforms.
AvailableMore RFPs available with Premium →
Get alerted before the bid drops, know which RFPs to pursue, and generate compliant drafts with AI.
Premium
Access the largest public sector contact database
Premium
Get complete source documentation & analysis